"Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs."
$1 billion, holy moly, that's a lot.
"The advances in foundational models come from the University of Washington's Institute of Protein Design, run by David Baker, one of Xaira's co-founders. These models are similar to diffusion models that power image generators like OpenAI's DALL-E and Midjourney. But rather than creating art, Baker's models aim to design molecular structures that can be made in a three-dimensional, physical world."
4 Likes
6 Comments